DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107. A total of 16 filers reported holding DENDREON CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $181,000 | -36.9% | 125,862 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $287,000 | -21.2% | 124,881 | +2.5% | 0.00% | -50.0% |
| Q1 2014 | $364,000 | 0.0% | 121,864 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $364,000 | -1.1% | 121,864 | -3.0% | 0.00% | 0.0% |
| Q3 2013 | $368,000 | -24.4% | 125,679 | +6.3% | 0.00% | -33.3% |
| Q2 2013 | $487,000 | – | 118,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 1,824,183 | $2,627,000 | 0.05% |
| ARISTEIA CAPITAL, L.L.C. | 1,000,000 | $1,440,000 | 0.05% |
| Quotient Investors, LLC | 156,100 | $225,000 | 0.05% |
| Spark Investment Management LLC | 208,900 | $300,000 | 0.04% |
| WOLVERINE ASSET MANAGEMENT LLC | 26,236 | $2,019,000 | 0.04% |
| TANG CAPITAL MANAGEMENT LLC | 55,548 | $80,000 | 0.04% |
| Point72 Asset Management, L.P. | 3,000,000 | $4,320,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 154,756 | $223,000 | 0.02% |
| Adamant Biomedical Investments AG | 50,000 | $72,000 | 0.02% |
| A.R.T. Advisors, LLC | 261,266 | $376,000 | 0.02% |